Kangas, Brian D. http://orcid.org/0000-0002-4597-9801
Wooldridge, Lisa M.
Luc, Oanh T.
Bergman, Jack
Pizzagalli, Diego A. http://orcid.org/0000-0002-7772-1143
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K01-DA035974)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R37-MH068376, R01-MH101521, UH2-MH109334)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 19 February 2020
Revised: 27 July 2020
Accepted: 29 July 2020
First Online: 13 August 2020
Conflict of interest
: Over the past 3 years, D.A.P. has received funding from NIMH, Brain and Behavior Research Foundation, the Dana Foundation, and Millennium Pharmaceuticals; consulting fees from Akili Interactive Labs, BlackThorn Therapeutics, Boehreinger Ingelheim, Compass Pathway, Posit Science, Otsuka Pharmaceuticals, and Takeda Pharmaceuticals; one honorarium from Alkermes; stock options from BlackThorn Therapeutics. D.A.P. has a financial interest in BlackThorn Therapeutics, which has licensed the copyright to the Probabilistic Reward Task through Harvard University. D.A.P.’s interests were reviewed and are managed by McLean Hospital and Partners HealthCare in accordance with their conflict of interest policies. All other authors report no biomedical financial interests or potential conflicts of interest.